期刊文献+

S-100、HMB-45和Tyrosinase在恶性黑色素瘤中的表达及其意义 被引量:5

The expression and significance of HMB-45,S-100 and Tyrosinase in malignant melanoma
下载PDF
导出
摘要 目的探讨S-100、HMB-45和Tyrosinase在恶性黑色素瘤(MM)诊断和鉴别诊断中的应用价值。方法采用免疫组化检测S-100、HMB-45和Tyrosinase在28例MM、17例良性痣中的表达,比较三种抗体对MM检测的敏感性和特异性。结果 S-100表达的敏感性较高(96.43%),但特异性低(5.89%);HMB-45表达的特异性较高(76.47%);Tyrosinase表达的敏感性较高(96.43%)。结论选择Tyrosinase和HMB-45联合标记,可有效提高恶性黑色素瘤诊断的敏感性和特异性。 Objective To explore the expression of HMB-45,S-100 and Tyrosinase as well as their significance in malignant melanoma(MM).Methods A series of antibodies including HMB-45,S-100 and Tyrosinase were used on paraffin sections in 28 cases of MM and 17 cases of benign nevus by immunohistochemical methods.Results The results showed that S-100 protein was highly sensitive(96.43%),but low specific(5.89%);HMB-45 was highly specific(76.47%);Tyrosinase was highly sensitive(96.43%).Conclusion Using Tyrosinase and HMB-45 together can increase the sensitivity and specificity for diagnosis of MM.
出处 《中国医药导报》 CAS 2012年第16期27-28,共2页 China Medical Herald
关键词 恶性黑色素瘤 免疫组化 S-100 HMB-45 TYROSINASE Malignant melanoma Immunohistochemical S-100 HMB-45 Tyrosinase
  • 相关文献

参考文献6

  • 1Markovic SN,Erickson LA,Rao RD,et al. Malignant melanoma in the 21st century,part 1 :epidcmiology, risk factors, screening, prevention, and diagnosis IJ]. Mayo Clin Proc,2007.82(3):364-380.
  • 2Jemal A,Murray T,Ward E,et al. Cancer statistics [J]. CA Cancer J Clin ,2005,55( 1 ) : 10-30.
  • 3Jemal A,Siegcl R,Ward E,et al. Cancer statistics [J]. CA Cancer J Clin, 2008,58 (2): 71-96.
  • 4O'Day SJ, Kim C J, Reintgen DS. Metastatic melanoma: chemotherapy to biochemotherapy [J]. Cancer Control, 2002,9 ( 1 ) : 31-38.
  • 5金艳,赵庆,王红梅.CT、MRI在脉络膜黑色素瘤中的诊断价值[J].中国医药导报,2010,7(10):134-134. 被引量:1
  • 6周克明,蒋炜杰,首峰,翁丽萍,白燕琼.恶性黑色素瘤22例临床分析[J].中国医药导报,2009,6(32):152-153. 被引量:7

二级参考文献9

共引文献6

同被引文献41

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部